For people living with unresolved pain, it’s more than just physical. The consequences can permeate one’s entire life. The ability to function, the capacity to work, the opportunity to live with dignity. All can be compromised.

We believe pain should not define someone’s life. We believe we must do better.

At Lilly, we are sparking a new conversation about unresolved pain. A conversation that challenges us to tackle the uniquely complex scientific and societal challenges of recurrent and chronic pain. To do so, we are committed to advancing the innovative science, policies and non-opioid medicines needed to reshape and enable a better approach to comprehensive pain management and treatment outcomes.


Current Medicines

Learn more

PP-MG-NZ-0018 04/2021